All systems operational
Q2 2026

miR-126-3p serves as a biomarker of inflammatory bowel disease (IBD) and modulates the molecular mechanisms of IBD through regulation of DICER1

Yingying Geng · Jingjing Peng · Qingzhi Chen
10.1016/j.ajg.2026.01.005 382 Views 0 Citations
0
Citations
382
Views
Abstract not available for this publication.
Cite this Article (APA)
Yingying, G., Jingjing, P., Qingzhi, C. (2026). miR-126-3p serves as a biomarker of inflammatory bowel disease (IBD) and modulates the molecular mechanisms of IBD through regulation of DICER1. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2026.01.005
Related Papers
Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A…
Qiufeng He; Chuangjie Mao; Zhili Chen; Yilan Zeng; Yang Deng; Rong Hu · 2024
11
cites
393
Chimeric antigen receptor-T cells targeting AFP-GPC3 mediate increased antitumor efficacy in hepatoc…
Mingxing Li; Tailin Chen; Rongshi Huang; Yanhui Cen; Feilan Zhao; Rong Fan; Guoz · 2025
10
cites
394
RETRACTED: miR-129-2-3p inhibits colon cancer cell proliferation by down-regulating the expression o…
Liang Tao; Peng Song; Lihua Shao; Hengfei Gao; Kangkang Ji; Yan Ren; Feng Wang; · 2024
8
cites
391
Access
View Full Text via DOI
Published in
ISSN 1687-1979
Quartile Q2
AMS Score 91
Field Medicine & Health Sciences
Publisher Arab Society of Gastroenterology /
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2026
Language English
Added 23 Jul 2026